BioCentury
ARTICLE | Clinical News

Ortho-McNeil regulatory update

March 8, 1999 8:00 AM UTC

Ortho-McNeil received approval to market Regranex becaplermin platelet-derived growth factor (PDGF) in Canada to treat full thickness lower extremity diabetic ulcers. Chiron Corp. (CHIR, Emeryville,...